Intracerebroventricular administration of olanzapine has shown to induce hyperglycemia and activation of AMPK in the hypothalamus of mice (98) via α-1 adrenoreceptor and D2 receptor-AMPK axis. The gene discussed is PRKAA2; the disease is Hyperglycemia.